Apr 20, 2017 – News Release – Appointment of Alan Arnstein

Mar 24, 2017 – News Release – Marketing Update

Feb 27, 2017 – News Release – Corporate Update – Sennace

Feb 07, 2017 – News Release – Corporate Update – New Sales People

Jan 31, 2017 – News Release – Corp. Update Letter from CEO

Jan 30, 2017 – News Release – Announce PP

Jan 27, 2017 – News Release – Corporate Update – Bob Rai as Interim CEO

Dec 05, 2016 – News Release – Health Tab Acquire

Nov 18, 2016 – News Release – Consolidation Approval

Nov 17, 2016 – News Release – Corporate Update

Nov 01, 2016 – News Release – Consolidation

July 05, 2016 – News Release – Option Plan Approved

June 20, 2016 – News-Release-Van-Fer-Approval

June 20, 2016 – News-Release- ANDS agreement

June 08, 2016 -News-Release-TSXV-Approval

May 26, 2016 -News Release- Amendment to terms of Warrants

May 17, 2016 – News Release – change of auditor

May 02, 2016 – Cortivera-H and Sales Force Update

April 08, 2016_Notice of the meeting and record date

March07, 2016 – News Release – Hema-Fer Launch

January 25, 2016 – News Release – TSXV Top 50

January 21, 2016 – News Release – David Hall directorship

December 30, 2015 – News Release – Corporate Update

October 22, 2015 – News Release – VANC Pharmaceuticals Commences Commercialization in Ontario

October 21, 2015_Notice of Change in Year End

October 7, 2015 – News Release – VANC Pharmaceuticals Announces Listing of Products on Six Provincial Formularies in Canada

September 22, 2015 – News Release – Vanc Pharmaceuticals Provides Corporate Update

July 8, 2015 – News Release – VANC Pharmaceuticals Commences Commercialization in British Columbia and Receives $1,095,728 in Proceeds from Warrant and Option Exercises

June 4, 2015 – News Release -VANC Pharmaceuticals Announces Appointment of Mr. Bob Rai to its Board of Directors

May 19, 2015 – News Release -VANC Pharmaceuticals Provides Corporate Update

May 4, 2015 – News Release – VANC Pharmaceuticals Announces Health Canada Approval for 5 New Generic Molecules and Provides Commercialization Update

April 2, 2015 – News Release – VANC Pharmaceuticals Adopts Advance Notice Policy

March 12, 2015 – News Release – VANC Pharmaceuticals Provides Corporate Update and Announces $2,000,000 in Proceeds from Warrant Exercises

March 6, 2015 – News Release – VANC Pharmaceuticals Announces Change of Auditor

February 24, 2015 – News Release – VANC Pharmaceuticals Announces Low Cost Alternative (LCA) Approval of 14 Products from British Columbia Ministry of Health

February 20, 2015 – News Release – VANC Pharmaceuticals Announces Supplier Letter of Intent with a Western Canadian Pharmacy Chain

February 12, 2015 – News Release – VANC director Michael Bianco has passed away

January 8, 2015 – News Release – VANC Pharmaceuticals Re-prices Options and Grants Incentive Stock Options

December 18, 2014 – News Release – VANC Pharmaceuticals Grants Incentive Stock Options

December 16, 2014 – News Release – VANC announces Additional Molecules

December 11, 2014 – News Release – VANC announces closure of PP

December 10, 2014 – News Release – VANC received Drug Establishment License (DEL)

December 08, 2014 – News Release – VANC announces conditional closing of PP

December 03, 2014 – News Release – VANC announces new CFO

November 27, 2014 – News Release – VANC announces Non Brokered Private Placement

November 19, 2014 – News Release: VANC announces approval of 4 NPNs from Health Canada for natural products

November 18, 2014 – News Release: VANC announces approval of 22 Generic Molecules by Health Canada

November 14, 2014 – Option Grant

August 6, 2014 – VANC Name Change

July 25, 2014 – NUVA Company Update

April 16, 2014 – NUVA Announces Licensing Agreements for 48 Generic Drugs for Canadian Markets

April 15, 2014 – NUVA Announces Licensing Agreements for Generics

April 8, 2014 – Nuva Announces Closing of Private Placement for Gross Proceeds of $375,000

March 21, 2014 – NUVA Announces Approval of Stock Option Plan

February 28, 2014 – NUVA Announces Non Brokered Private Placement

February 28, 2014 – NUVA Announces Non Brokered Private Placement to Raise Capital

February 21, 2014 – OTC Symbol Change

February 3, 2014 – NUVA Announces Annual General Meeting Results

November 25, 2013 – NUVA Welcomes Arun Nayyar as Chief Executive Officer

October 25, 2013 – NUVA Welcomes Sina Pirooz To The Board

September 04, 2013 – NUVA Completes Product Acquisition Agreement

August 01, 2013 – ALDA Pharmaceuticals Corp. Changes Name

July 24, 2013 – Board changes at ALDA

July 12, 2013 – ALDA enters into MoU for Joint Venture

June 12, 2013 – ALDA Pharmaceuticals Closes Private Placement

May 10, 2013 – ALDA AGM

March 21, 2013 – Proposed Non Brokered Private Placement Financing